Showing results (241-250 of 324) with videos related to
Sort By:
Pageof 33
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2020
Circulating Tumor Cells and Early Relapse in Node-positive MelanomaAnthony Lucci, Carolyn S Hall, Sapna P Patel, et al.Oncoimmunology|August 15, 2025
Lymphodepletion, tumor-infiltrating lymphocytes, and high versus low dose IL-2 followed by pembrolizumab in patients with metastatic melanomaMerve Hasanov, Simin Kiany, Marie-Andrée Forget, et al.Science (New York, N.Y.)|September 21, 2002
Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytesMark E Dudley, John R Wunderlich, Paul F Robbins, et al.Scientific Reports|October 2, 2025
Preclinical models of melanoma leptomeningeal disease to assess intrathecal checkpoint blockadeRenato A Guerrieri, Grant M Fischer, Jacob R Cortez, et al.Oncoimmunology|December 14, 2020
A Phase 1b Study Evaluating the Safety, Tolerability, and Immunogenicity of CMB305, a Lentiviral-Based Prime-Boost Vaccine Regimen, in Patients with Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1Neeta Somaiah, Sant P Chawla, Matthew S Block, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2012
Phase II study of the MEK1/MEK2 inhibitor Trametinib in patients with metastatic BRAF-mutant cutaneous melanoma previously treated with or without a BRAF inhibitorKevin B Kim, Richard Kefford, Anna C Pavlick, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 2, 2012
Oncogenic BRAF(V600E) promotes stromal cell-mediated immunosuppression via induction of interleukin-1 in melanomaJahan S Khalili, Shujuan Liu, Tania G Rodríguez-Cruz, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2012
Phase I study of the combination of sorafenib and temsirolimus in patients with metastatic melanomaMichael A Davies, Patricia S Fox, Nicholas E Papadopoulos, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2012
BRAF inhibition increases tumor infiltration by T cells and enhances the antitumor activity of adoptive immunotherapy in miceChengwen Liu, Weiyi Peng, Chunyu Xu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 12, 2013
BRAF inhibition is associated with enhanced melanoma antigen expression and a more favorable tumor microenvironment in patients with metastatic melanomaDennie T Frederick, Adriano Piris, Alexandria P Cogdill, et al.Pageof 33